Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Director
Kolb, Noah Allan

University Of Vermont & St Agric College
United States

Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy 5R01CA247517-02 Alexis Bakos, Ph.D., M.P.H., R.N.
Krause, Diane S

Yale University
United States

"Exploration of Human Parathyroid Cellular Organization and Function" 1R21CA240660-01A1 Cecilia Lee, Dr.P.H., R.N.
Kroetz, Deanna L

University Of California, San Francisco
United States

Contribution of Nuclear S1P Signaling to Microtubule Targeting Agent-Induced Changes in Transcriptional Activity in Human iPS-SNs 3R01CA261068-02S1 Alexis Bakos, Ph.D., M.P.H., R.N.
Lad, Thomas

Hektoen Institute For Medical Research
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal 5UG1CA190000-09 Worta McCaskill-Stevens, M.D., M.S.
Ladas, Elena J.

Columbia University Health Sciences
United States

Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer 5R01CA201788-07 Alexis Bakos, Ph.D., M.P.H., R.N.
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP MU 5UG1CA189855-09 Worta McCaskill-Stevens, M.D., M.S.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 PAR-20-292 (R21 Clinical Trial Optional) Alexis Bakos, Ph.D., M.P.H., R.N.
Lesser, Glenn J

Wake Forest University Health Sciences
United States

Clinical Studies NCORP Boot Camp Program for Early-Career Investigators 3UG1CA189824-09S2 Worta McCaskill-Stevens, M.D., M.S.
Levine, Jon David

University Of California, San Francisco
United States

Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress 5R01CA250017-04 Alexis Bakos, Ph.D., M.P.H., R.N.
Lin, Po-Ju

University Of Rochester
United States

Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy 1R21CA256154-01A1 PAR-20-292 (R21 Clinical Trial Optional) Marge Good, R.N., M.P.H., O.C.N.